MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$1,146,096
EPS
$0.13
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
Research and development
165,577 443,541.5*
General and administrative
978,576 910,194.25*
Total operating expenses
1,144,153 1,353,735.75
Loss from operations
-1,144,153 -1,353,735.75*
Interest expense
1,943 18,164.75*
Loss on change in fair value of derivative liabilities
--1,578*
Loss (gain) on extinguishment of debt
-81,586.25*
Total other expense (income), net
-1,943 61,843.5*
Loss before provision for income taxes
-1,146,096 -1,291,892.25
Net loss
-1,146,096 -1,291,892.25
Basic EPS
-0.13 -0.165
Diluted EPS
0.13 -0.165
Basic Average Shares
8,701,837 7,812,264
Diluted Average Shares
8,701,837 7,812,264
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$1,146,096 Loss beforeprovision for income taxes-$1,146,096 Loss from operations-$1,144,153 Total other expense(income), net-$1,943 Total operatingexpenses$1,144,153 Interest expense$1,943 General andadministrative$978,576 Research and development$165,577

ADAPTIN BIO, INC. (APTN)

ADAPTIN BIO, INC. (APTN)